Likewise, inhibition of MDSCs with IPI-145, a selective inhibitor of PI3Kδ and PI3Kγ isoforms, in combination with anti-PD-L1 induced CD8+ T cell-dependent tumor growth reduction in a head and neck cancer mouse model (Davis et al., 2017). The gene discussed is CD8A; the disease is neoplasm.